These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 36698747)

  • 41. Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function.
    Boertien WE; Meijer E; de Jong PE; ter Horst GJ; Renken RJ; van der Jagt EJ; Kappert P; Ouyang J; Engels GE; van Oeveren W; Struck J; Czerwiec FS; Oberdhan D; Krasa HB; Gansevoort RT
    Am J Kidney Dis; 2015 Jun; 65(6):833-41. PubMed ID: 25600953
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combination drug versus monotherapy for the treatment of autosomal dominant polycystic kidney disease.
    Rysz J; Gluba-Brzózka A; Franczyk B; Banach M; Bartnicki P
    Expert Opin Pharmacother; 2016 Oct; 17(15):2049-56. PubMed ID: 27650472
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The STAGED-PKD 2-Stage Adaptive Study With a Patient Enrichment Strategy and Treatment Effect Modeling for Improved Study Design Efficiency in Patients With ADPKD.
    Perrone RD; Hariri A; Minini P; Ahn C; Chapman AB; Horie S; Knebelmann B; Mrug M; Ong ACM; Pei YPC; Torres VE; Modur V; Gansevoort RT
    Kidney Med; 2022 Oct; 4(10):100538. PubMed ID: 36204243
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protocol for the nationwide registry of patients with polycystic kidney disease: japanese national registry of PKD (JRP).
    Nakatani S; Kawano H; Sato M; Hoshino J; Nishio S; Miura K; Sekine A; Suwabe T; Hidaka S; Kataoka H; Ishikawa E; Shimazu K; Uchiyama K; Fujimaru T; Moriyama T; Kurashige M; Shimabukuro W; Hattanda F; Kimura T; Ushio Y; Manabe S; Watanabe H; Mitobe M; Seta K; Shimada Y; Kai H; Katayama K; Ichikawa D; Hayashi H; Hanaoka K; Mochizuki T; Nakanishi K; Tsuchiya K; Horie S; Isaka Y; Muto S;
    Clin Exp Nephrol; 2024 Oct; 28(10):1004-1015. PubMed ID: 38734869
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hyponatremia and cyst growth in neonatal polycystic kidney disease: a case for aquaretics?
    Bockenhauer D
    Pediatr Nephrol; 2017 May; 32(5):721-723. PubMed ID: 28194573
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Translational research approaches to study pediatric polycystic kidney disease.
    Liebau MC; Mekahli D
    Mol Cell Pediatr; 2021 Dec; 8(1):20. PubMed ID: 34882278
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of tolvaptan in a patient with autosomal dominant polycystic kidney disease after living donor liver transplantation.
    Uchiyama K; Honda K; Yoshida R; Kamijo Y; Yanagi M; Nakatsuka M; Ishibashi Y
    CEN Case Rep; 2016 Nov; 5(2):227-231. PubMed ID: 28508983
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of Statin Therapy on the Progression of Autosomal Dominant Polycystic Kidney Disease. A Secondary Analysis of the HALT PKD Trials.
    Brosnahan GM; Abebe KZ; Rahbari-Oskoui FF; Patterson CG; Bae KT; Schrier RW; Braun WE; Chapman AB; Flessner MF; Harris PC; Perrone RD; Steinman TI; Torres VE;
    Curr Hypertens Rev; 2017; 13(2):109-120. PubMed ID: 28460625
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Effect of Dietary Intervention on Autosomal-Dominant Polycystic Kidney Disease (ADPKD) Patients on Tolvaptan and Their Quality of Life.
    Tarabzuni O
    Cureus; 2022 May; 14(5):e25045. PubMed ID: 35719821
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Feline polycystic kidney disease is linked to the PKD1 region.
    Mamm Genome; ; . PubMed ID: 15674734
    [TBL] [Abstract][Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.